Skip to main content
. 2001 Feb;183(4):1369–1375. doi: 10.1128/JB.183.4.1369-1375.2001

TABLE 1.

Strains and plasmids used in this study

Strain or plasmid Relevant characteristicsa Source or reference
V. vulnificus
 YJ016 Clinical isolate Laboratory collection
 YJ024 Translucent mutant of YJ016 9
 CP080 YJ016 Δvvp 30
 CP154 YJ016 smcR::pVR19 This study
 CP156 YJ016 ΔsmcR This study
 CP194 CP156/pVR21 This study
E. coli
 DH5α supE44 lacU169 (φ80lacZΔM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 7
 SM10λpir thi thr leu tonA lacY supE recA::RP4-2-Tc::Mu λpir Kmr Nalr 16
 LLM1956 DH5α/pRS205 14
Plasmids
 pRS205 pUC19 with the lux operon of V. harveyi 14
 pJRD215 Shuttle vector; Kmr 5
 pUC19 Cloning vector; Apr Laboratory collection
 pCVD442 Suicide vector; Apr 6
 pVR11 pBR322 inserted with a 3.3-kb fragment containing the intact smcR gene This study
 pVR18 pVR11 with a 445-bp deletion in smcRsmcR) This study
 pVR19 pCVD442 with the NheI-NheI fragment that contains ΔsmcR cloned from pVR18 This study
 pVR21 pJRD215 with the NheI-NheI fragment that contains the intact smcR cloned from pVR11 This study
 pVR22 pJRD215 with the NheI-NheI fragment that contains ΔsmcR cloned from pVR18 This study
a

Abbreviations: Apr, Kmr, and Nalr are resistance to ampicillin, kanamycin, and nalidixic acid, respectively. 

HHS Vulnerability Disclosure